These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16003930)

  • 1. Assessment of everyday behavior in Alzheimer's disease patients: its significance for diagnostics and prediction of disease progression.
    Bläsi S; Brubacher D; Zehnder AE; Monsch AU; Berres M; Spiegel R
    Am J Alzheimers Dis Other Demen; 2005; 20(3):151-8. PubMed ID: 16003930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the NOSGER (Nurses' Observation Scale for Geriatric Patients): reliability and validity of a caregiver rating instrument.
    Wahle M; Häller S; Spiegel R
    Int Psychogeriatr; 1996; 8(4):525-47. PubMed ID: 9147168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients).
    Spiegel R; Brunner C; Ermini-Fünfschilling D; Monsch A; Notter M; Puxty J; Tremmel L
    J Am Geriatr Soc; 1991 Apr; 39(4):339-47. PubMed ID: 2010583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lawton Instrumental Activities Daily Living/Activities Daily Living Scales: A Sensitive Test to Alzheimer Disease in Community-Dwelling Elderly People?
    Koskas P; Henry-Feugeas MC; Feugeas JP; Poissonnet A; Pons-Peyneau C; Wolmark Y; Drunat O
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):85-93. PubMed ID: 24578460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.
    Bodick NC; Offen WW; Levey AI; Cutler NR; Gauthier SG; Satlin A; Shannon HE; Tollefson GD; Rasmussen K; Bymaster FP; Hurley DJ; Potter WZ; Paul SM
    Arch Neurol; 1997 Apr; 54(4):465-73. PubMed ID: 9109749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantification of dementia-related disabilities in daily behavior with the DAFS (Direct Assessment of Functional Status): reliability and validity of a German test version].
    Hochrein A; Jonitz L; Hock C; Bell V; Plaum E; Engel RR
    Z Gerontol Geriatr; 1996; 29(3):216-22. PubMed ID: 8767019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach.
    Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M
    Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
    Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
    Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional decline in Alzheimer's disease: a longitudinal study.
    Green CR; Mohs RC; Schmeidler J; Aryan M; Davis KL
    J Am Geriatr Soc; 1993 Jun; 41(6):654-61. PubMed ID: 8505464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
    J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CERAD and NOSGER. Comparing predictive scales for dementia in a Swiss gerontopsychiatric patient population].
    Künig G; Kaldune A; Stief V; Jäger M; Hell D; Endrass J; Schreiter Gasser U
    Nervenarzt; 2007 Mar; 78(3):314, 316-21. PubMed ID: 16404633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting depression in Alzheimer's disease: evaluation of four different scales.
    Müller-Thomsen T; Arlt S; Mann U; Mass R; Ganzer S
    Arch Clin Neuropsychol; 2005 Mar; 20(2):271-6. PubMed ID: 15708735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Erlangen Test of Activities of Daily Living: first results on reliability and validity of a short performance test to measure fundamental activities of daily living in dementia patients.
    Graessel E; Viegas R; Stemmer R; Küchly B; Kornhuber J; Donath C
    Int Psychogeriatr; 2009 Feb; 21(1):103-12. PubMed ID: 18925975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perturbations of activities of daily living in Alzheimer's disease. A study of 172 patients with the using a questionnaire completed by caregivers].
    Derouesné C; Thibault S; Lozeron P; Baudouin-Madec V; Piquard A; Lacomblez L
    Rev Neurol (Paris); 2002 Jul; 158(6-7):684-700. PubMed ID: 12486898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of impartial assessment of geriatric brain diseases].
    Spiegel R
    Ther Umsch; 1997 Jun; 54(6):314-20. PubMed ID: 9289868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.
    Bellelli G; Lucchi E; Minicuci N; Rozzini L; Bianchetti A; Padovani A; Trabucchi M
    Aging Clin Exp Res; 2005 Feb; 17(1):54-61. PubMed ID: 15847123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer's disease.
    Harwood DG; Barker WW; Ownby RL; Duara R
    Int J Geriatr Psychiatry; 2000 May; 15(5):393-400. PubMed ID: 10822237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.